Coronary Artery Disease Clinical Trials

51 studies are recruiting for coronary artery disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. Product Surveillance Registry

    The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

    Stage
    Not phased
    Ages
    Any age
    Site
    Research site, Birmingham, Alabama
    Locations
    401 in total
    Run by
    Medtronic
  2. Factors Affect Outcomes in Cardiovascular Surgery

    Identify factors that contribute to perioperative morbidity and mortality in patients undergoing cardiac surgery that involves cardiopulmonary bypass. Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California Davis Health System, Sacramento, California
    Run by
    University of California, Davis
  3. Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy

    This prospective, non-blinded, single-center, translational research study aims to validate a multimodal advanced imaging exam for cardiac viability. The protocol utilizes three distinct imaging modalities: Single Photon Emission Computed Tomography Myocardial Perfusion Imaging (SPECT MPI), 18F-flu…

    Stage
    Not phased
    Ages
    20 to 80
    Site
    University of Texas Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  4. Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

    Heart failure due to coronary artery disease represents a significant cause of mortality. The detection of patients eligible for bypass surgery is a pivotal concern. Nevertheless, the optimal approach for patient selection based on conventional imaging scans remains unclear. The proposed method (Hy…

    Stage
    Not phased
    Ages
    20 to 80
    Site
    University of Texas Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  5. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

    This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Alabama Cardiology PC, Birmingham, Alabama
    Locations
    14 in total
    Run by
    XyloCor Therapeutics, Inc.
  6. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

    The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Loma Linda University Medical Center, Loma Linda, California
    Locations
    19 in total
    Run by
    Supira Medical
  7. Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia

    This study is being done to observe the effects of treatment from a device called the Bioboosti which utilizes pulsed electromagnetic waves on its ability to improve blood flow to the heart tissue in individuals with coronary artery disease (CAD).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic in Arizona, Scottsdale, Arizona
    Locations
    2 in total
    Run by
    Mayo Clinic
  8. A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

    This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    40 in total
    Run by
    Beijing Inno Medicine Co., Ltd.
  9. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

    This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an o…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Adventist Health Glendale, Glendale, California
    Locations
    18 in total
    Run by
    Weill Medical College of Cornell University
  10. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

    This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Adventist Health Glendale, Glendale, California
    Locations
    18 in total
    Run by
    Weill Medical College of Cornell University
  11. A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

    The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current standard of care (IVUS-…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Minneapolis Heart Institute, Minneapolis, Minnesota
    Locations
    14 in total
    Run by
    Fundación EPIC
  12. Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

    The objective of this study is to assess the safety and efficacy of the Freesolve resorbable magnesium scaffold (RMS) in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to the Xience coronary drug-eluting stent (DES) system

    Stage
    Not phased
    Ages
    18 to 80
    Site
    MedStar Washington Hospital Center, Washington D.C., District of Columbia
    Locations
    3 in total
    Run by
    Teleflex
  13. Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention

    The CT-PLAN PCI trial will evaluate whether CCTA-guided PCI improves procedural efficiency compared with routine PCI (without pre-procedural CCTA-guidance for PCI planning) using procedural time as the primary endpoint. Key secondary outcomes will include contrast volume, radiation dose, fluoroscop…

    Stage
    Not phased
    Ages
    22 and older
    Site
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
    Run by
    Minneapolis Heart Institute Foundation
  14. Randomization of Single vs Multiple Arterial Grafts

    The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a single arterial graft is associated with a reduction in the composite outcome of death from any cause, any stroke, …

    Stage
    Not phased
    Ages
    18 to 70
    Site
    University of Colorado, Boulder, Colorado
    Locations
    59 in total
    Run by
    Weill Medical College of Cornell University
  15. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

    Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

    Stage
    Not phased
    Ages
    Any age
    Site
    Little Rock VA Medical Center, Little Rock, Arkansas
    Locations
    48 in total
    Run by
    Minneapolis Heart Institute Foundation
  16. Progress Complication

    Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center obse…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
    Run by
    Minneapolis Heart Institute Foundation
  17. Progress Bifurcation Global Registry

    Coronary bifurcation lesions are lesions (or blockages) that occur at or near the intersection of a major coronary artery and one of the arteries' side branches. Numerous techniques and devices have been developed to treat coronary bifurcations; however, these types of lesions remain some of the mo…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
    Run by
    Minneapolis Heart Institute Foundation
  18. Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

    Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant

    Stage
    Not phased
    Ages
    18 to 99
    Site
    Indiana University, Indianapolis, Indiana
    Run by
    Indiana University
  19. Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

    The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) >36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d…

    Stage
    Not phased
    Ages
    18 and older
    Site
    John Muir Medical Center, Concord, California
    Locations
    23 in total
    Run by
    Teleflex
  20. Virtue® SAB in the Treatment of Coronary ISR Trial

    A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

    Stage
    Not phased
    Ages
    18 and older
    Site
    The Cardiac and Vascular Institute, Gainesville, Florida
    Locations
    15 in total
    Run by
    Orchestra BioMed, Inc
  21. SELUTION 4 De Novo Small Vessel IDE Trial

    Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

    Stage
    Not phased
    Ages
    18 and older
    Site
    St. Bernards, Jonesboro, Arkansas
    Locations
    70 in total
    Run by
    M.A. Med Alliance S.A.
  22. Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment

    The NODULE-SHOCK trial is a prospective, investigator-initiated, single-center, randomized controlled trial designed to compare the efficacy of intravascular lithotripsy (IVL) with or without rotational atherectomy (RA) in patients with coronary calcified nodules (Cohort A), and operator-determined…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mount Sinai Hospital, New York, New York
    Run by
    Annapoorna Kini
  23. Hybrid Group Singing

    The overall objective of the planned future clinical trial is to test the investigator's central hypothesis that habitual singing over several weeks, similar to habitual exercise, will lead to sustained and favorable vascular adaptation, thereby lowering cardiovascular disease (CVD) risk. The overa…

    Stage
    Not phased
    Ages
    55 to 89
    Site
    Medical College of Wisconsin, Milwaukee, Wisconsin
    Run by
    Medical College of Wisconsin
  24. ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

    The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Emory University Hospital Midtown, Atlanta, Georgia
    Locations
    19 in total
    Run by
    Emory University
  25. Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

    Traditionally, the severity of a blockage (stenosis) in a coronary artery has been determined by visual angiographic assessment of the diameter of the artery at the level of a blockage compared to a normal healthy area of the same artery. With the advent of invasive physiological testing to assess …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Run by
    Beth Israel Deaconess Medical Center

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.